Multiple sclerosis-related central pain disorders

Current Pain and Headache Reports

Volumn 14, Issue 3, 2010, Pages 189-195

  Nurmikko, Turo J ^a   Gupta, Sameer ^b   Maclver, Kate ^c  

^a Clinical Sciences Centre   (United Kingdom)

^b THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Central pain; Lhermitte's sign; Multiple sclerosis; Painful tonic spasms; Trigeminal nerulagia

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; BACLOFEN; CANNABIDIOL; CANNABINOID; CARBAMAZEPINE; DRONABINOL; DULOXETINE; ETIRACETAM; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LEVORPHANOL; MISOPROSTOL; MORPHINE; NARCOTIC ANALGESIC AGENT; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; OMEGA CONOTOXIN MVIIA; OXCARBAZEPINE; PLACEBO; PREGABALIN; SEDATIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DYSESTHESIA; HUMAN; INTRACTABLE PAIN; LHERMITTE SIGN; LOW BACK PAIN; LOW DRUG DOSE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; MYOTONIA; NEUROIMAGING; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PAIN ASSESSMENT; PAIN PARAMETERS; PREVALENCE; QUALITY OF LIFE; REVIEW; SENSORY DYSFUNCTION; SOCIAL PSYCHOLOGY; SPINAL CORD STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCUTANEOUS NERVE STIMULATION; TRIGEMINUS NEURALGIA; CENTRAL NERVOUS SYSTEM; COMPLICATION; NEURALGIA; PATHOPHYSIOLOGY;

CENTRAL NERVOUS SYSTEM; HUMANS; MULTIPLE SCLEROSIS; NEURALGIA;

EID: 77956365231     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-010-0108-8     Document Type: Review

References (50)

1. Lassmann H, Brück W, Lucchinetti CF: The immunopathology of multiple sclerosis: An overview. Brain Pathol 2007, 17:210-218.
2. Solaro C, Brichetto G, Amato MP, et al.: The prevalence of pain in multiple sclerosis: A multicenter, cross-sectional study. Neurology 2004, 63:919-921.
3. Boneschi FM, Colombo B, Annovazzi B, et al.: Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler 2008, 14:514-521.
4. Svendsen KB, Jensen TS, Overvad K, et al.: Pain in patients with multiple sclerosis. A population-based study. Arch Neurol 2003, 60:1089-1094.
5. Knight YE, Goadsby PJ: The periaqueductal grey matter modulates trigeminovascular input: A role in migraine? Neuroscience 2001, 106:793-800.
6. Welch KM, Nagesh V, Aurora SK, Gelman N: Periaqueductal grey matter dysfunction in migraine: Cause or the burden of illness? Headache 2001, 41:629-637.
7. O'Connor AB, Schwid SR, Herrmann DN, et al.: Pain associated with multiple sclerosis: Systematic review and proposed classification. Pain 2008, 137:96-111. This comprehensive and informative review discusses pain associated with MS.
8. Putzki N, Pfriem A, Limmroth V, et al.: Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 2009, 16:262-267.
9. Ehde DM, Gibbons LE, Chwastiak L, et al.: Chronic pain in a large community sample of persons with multiple sclerosis. Mult Scler 2003, 9:605-611.
10. Vermote R, Ketelaer P, Carton H: Pain in multiple sclerosis patients. Clin Neurol Neurosurg 1996, 88:87-93.
11. Hadjimichael O, Kerns RD, Rizzo MA, et al.: Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain 2007, 127:35-41.
12. Beiske AG, Pedersen ED, Czujko B, Myhr KM: Pain and sensory complaints in multiple sclerosis. Eur J Neurol 2004, 11:479-482.
13. Grasso MG, Clemenzi A, Tonini A, et al.: Pain in multiple sclerosis: A clinical and instrumental approach. Mult Scler 2008, 14:506-513.
14. Pöllmann W, Feneberg W: Current management of pain associated with multiple sclerosis. CNS Drugs 2008, 22:291-324.
15. Osterberg A, Boivie J, Thuomas KA: Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain 2005, 9:531-542.
16. Moulin DE, Foley KM, Ebers GC: Pain syndromes in multiple sclerosis. Neurology 1988, 38:1830-1834.
17. Olechowski CJ, Truong JJ, Kerr BJ: Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 2009, 141:156-164.
18. Attal N, Cruccu G, Haanpää M, et al.: EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006, 13:1153-1169.
19. Rossi S, Mataluni G, Codecà C, et al.: Effects of levetiracetam on chronic pain in multiple sclerosis: Results of a pilot, randomized, placebo-controlled study. Eur J Neurol 2009, 16:360-366.
20. Breuer B, Pappagallo M, Knotkova H, et al.: A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin Ther 2007, 29:2022-2030.
21. Rowbotham MC, Twilling L, Davies PS, et al.: Oral opioid therapy for chronic peripheral and central pain. N Engl J Med 2003, 348:1223-1232.
22. Svendsen KB, Jensen TS, Bach FW: Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 2004, 329:253.
23. Rog DJ, Nurmikko TJ, Friede T, Young CA: Randomised controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005, 65:812-819.
24. 9- tetrahydrocannabinol/ cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial. Clin Ther 2007, 29:2068-2079.
25. Becker R, Uhle EI, Alberti O, Bertalanffy H: Continuousintrathecal baclofen infusion in the management of central deafferentation pain. J Pain Symptom Manage 2000, 20:313-315.
26. Sadiq SA, Poopatana CA: Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity. J Neurol 2007, 254:1464-1465.
27. Kumar K, Hunter G, Demeria D: Spinal cord stimulation in treatment of chronic benign pain: Challenges in treatment planning and present status, a 22-year experience. Neurosurgery 2006, 58:481-496.
28. Chitsaz A, Janhorbani M, Shaygannejad V, et al.: Sensory complaints of the upper extremities in multiple sclerosis: Relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation. Clin J Pain 2009, 24:281-285.
29. Jensen MP, Barber J, Romano JM, et al.: A comparison of selfhypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. Int J Clin Exp Hypn 2009, 57:198-221.
30. Zorro O, Lobato-Polo J, Kano H, et al.: Gamma knife surgery for multiple sclerosis related trigeminal neuralgia. Neurology 2009, 73:1149-1154.
31. Gass A, Kitchen N, MacManus DG, et al.: Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology 1997, 49:1142-1144.
32. Arrese I, Lagares A, Alday R, et al.: Typical trigeminal neuralgia associated with brainstem white matter lesions on MRI in patients without criteria of multiple sclerosis. Acta Neurochir (Wien) 2008, 150:1157-1161.
33. Da Silva CJ, da Rocha AJ, Mendes MF, et al.: Trigeminal involvement in multiple sclerosis: Magnetic resonance imaging findings with clinical correlation in a series of patients. Mult Scler 2005, 11:282-285.
34. Meaney JF, Watt JW, Eldridge PR, et al.: Association between trigeminal neuralgia and multiple sclerosis: Role of magnetic resonance imaging. J Neurol Neurosurg Psychiatry 1995, 59:253-259.
35. Love S, Gradidge T, Coakham HB: Trigeminal neuralgia due to multiple sclerosis: ultrastructural findings in trigeminal rhizotomy specimens. Neuropathol Appl Neurobiol 2001, 27:238-244.
36. Cruccu G, Biasiotta A, Di Rezze S, et al.: Trigeminal neuralgia and pain related to multiple sclerosis. Pain 2009, 143:186-191. This is an excellent example of a systematic approach to unravelling pathophysiological mechanisms in a specific pain condition.
37. Pickett GE, Bisnaire D, Ferguson GG: Percutaneous retrogasserian glycerol rhizotomy in the treatment of tic douloureux associated with multiple sclerosis. Neurosurgery 2005, 56:537-545.
38. Eldridge PR, Sinha AK, Javadpour M, et al.: Microvascular decompression for trigeminal neuralgia in patients with multiple sclerosis. Stereotact Funct Neurosurg 2003;81:57-64.
39. Broggi G, Ferroli P, Franzini A, et al.: Operative findings and outcomes of microvascular decompression in 35 patients affected by multiple sclerosis. Neurosurgery 2004, 55:830-839.
40. Kanpolat Y, Berk C, Savas A, Bekar A: Percutaneous controlled radiofrequency rhizotomy in the management of patients with trigeminal neuralgia due to multiple sclerosis. Acta Neurochir (Wien) 2000, 142:685-689; discussion 689-690.
41. Solaro C, Tanganelli P, Messmer Uccelli M: Pharmacological treatment of pain in multiple sclerosis. Exp Rev Neurother 2007, 7:1165-1174.
42. DMKG Study Group: Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J Neurol 2003, 250:542-545.
43. Matthews WB: Tonic seizures in disseminated sclerosis. Brain 1958, 81:193-206.
44. Spissu A, Cannas A, Ferrigno P, et al.: Anatomic correlates of painful tonic spasms in multiple sclerosis. Mov Disord 1999, 14:331-335.
45. Waubant E, Alizé P, Tourbah A, Agid Y: Paroxysmal dystonia (tonic spasm) in multiple sclerosis. Neurology 2001, 57:2320-2321.
46. Rose MR, Ball JA, Thompson PD: Magnetic resonance imaging in tonic spasms of multiple sclerosis. J Neurol 1993;241:115-117.
47. Kanchandani R, Howe JG: Lhermitte's sign in multiple sclerosis: A clinical survey and review of the literature. J Neurol Neurosurg Psychiatry 1982, 45:308-312.
48. Al-Araji AH, Oger J: Reappraisal of Lhermitte's sign in multiple sclerosis. Mult Scler 2005, 11:398-402.
49. Kalia LV, O'Connor PW: Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler 2005, 11:322-327.
50. Osbourne TL, Jensen MP, Ehde DM, et al.: Psychosocial factors associated with pain intensity, pain-related interference, and pschological functioning in patients with multiple sclerosis and pain. Pain 2007, 127:52-62.